Liu W, Yu S, Yan B (2022) <br />Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus<br /><i>Biochemical Pharmacology</i> <b>204</b>: 115224<br /><br />Li J, Shi J, Xiao J, Tran L, Wang X, Zhu HJ (2021) <br />Contributions of Cathepsin A and Carboxylesterase 1 to the hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis<br /><i>Drug Metabolism & Disposition: The Biological Fate of Chemicals</i> <br /><br />Li J, Liu S, Shi J, Zhu HJ (2021) <br />Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection<br /><i>Pharmaceutics</i> <b>13</b>: <br /><br />Birkus G, Bam RA, Willkom M, Frey CR, Tsai L, Stray KM, Yant SR, Cihlar T (2015) <br />Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors<br /><i>Antimicrobial Agents & Chemotherapy</i> <b>60</b>: 316<br /><br />Murakami E, Wang T, Park Y, Hao J, Lepist EI, Babusis D, Ray AS (2015) <br />Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy<br /><i>Antimicrobial Agents & Chemotherapy</i> <b>59</b>: 3563<br /><br />Bam RA, Birkus G, Babusis D, Cihlar T, Yant SR (2014) <br />Metabolism and antiretroviral activity of tenofovir alafenamide in CD4+ T-cells and macrophages from demographically diverse donors<br /><i>Antivir Ther</i> <b>19</b>: 669<br /><br />Birkus G, Kutty N, He GX, Mulato A, Lee W, McDermott M, Cihlar T (2008) <br />Activation of 9-[(R)-2-[[(S)-[[(S)-1-(Isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases<br /><i>Molecular Pharmacology</i> <b>74</b>: 92<br /><br />